Groowe Groowe / Newsroom / ATOS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ATOS News

Atossa Therapeutics, Inc. Common Stock

Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds

prnewswire.com
ATOS

Form 8-K

sec.gov
ATOS

Atossa Therapeutics Announces Registered Direct Offering of up to $16.5 Million in Gross Proceeds

prnewswire.com
ATOS

Qevlar vereint SOC und Vulnerability Management mit neuen KI-Agenten und verkleinert so die Angriffsfläche

businesswire.com
ATOS

Atossa Therapeutics Announces ASCO 2026 Abstracts Highlighting (Z)-Endoxifen Activity Across ESR1 Mutations and Ongoing EVANGELINE Phase 2 Trial

prnewswire.com
ATOS

Atossa Therapeutics Announces Acceptance of Manuscript Highlighting Utrophin-Modulation Potential of (Z)-Endoxifen in Duchenne Muscular Dystrophy

prnewswire.com
ATOS

Atos Selected by Viasat to Modernize Global Digital Workplace Operations

globenewswire.com
ATOS

Atossa Therapeutics to Host Virtual KOL Event Featuring Dr. Laura Esserman to Discuss Development of (Z)-Endoxifen in ER-Positive Breast Cancer

prnewswire.com
ATOS

EUROCONTROL Scales Air Traffic Innovation and Digital Sovereignty with Red Hat

businesswire.com
ATOS

Form 8-K

sec.gov
ATOS